Adverse Drug Reaction Classification System

         

Pharmaceutical Information
Drug Name Aminolevulinic acid hydrochloride
Drug ID BADD_D00111
Description A compound produced from succinyl-CoA and glycine as an intermediate in heme synthesis. It is used as a photochemotherapy for actinic keratosis. [PubChem]
Indications and Usage Aminolevulinic acid plus blue light illumination using a blue light photodynamic therapy illuminator is indicated for the treatment of minimally to moderately thick actinic keratoses of the face or scalp.
Marketing Status approved
ATC Code L01XD04
DrugBank ID DB00855
KEGG ID D02908
MeSH ID D000622
PubChem ID 123608
TTD Drug ID D0O4GY
NDC Product Code 67308-101; 70621-101; 59137-231; 71956-001
UNII V35KBM8JGR
Synonyms Aminolevulinic Acid | Acid, Aminolevulinic | Delta-Aminolevulinic Acid | Acid, Delta-Aminolevulinic | Delta Aminolevulinic Acid | Levulan | 5-Aminolaevulinate | 5 Aminolaevulinate | 5-Aminolevulinate | 5 Aminolevulinate | Aminolevulinic Acid Hydrochloride | Acid Hydrochloride, Aminolevulinic | Hydrochloride, Aminolevulinic Acid
Chemical Information
Molecular Formula C5H10ClNO3
CAS Registry Number 5451-09-2
SMILES C(CC(=O)O)C(=O)CN.Cl
Chemical Structure
ADRs Induced by Drug
*The priority for ADR severity classification is based on FAERS assessment, followed by the most severe level in CTCAE rating. If neither is available, it will be displayed as 'Not available'.
**The 'Not Available' level is hidden by default and can be restored by clicking on the legend twice.
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Blister12.01.06.002; 23.03.01.001---
Burning sensation08.01.09.029; 17.02.06.001---
Diplopia06.02.06.002; 17.17.01.005---
Discomfort08.01.08.003---
Dysaesthesia17.02.06.003; 23.03.03.077--
Erythema23.03.06.001---
Eye discharge06.04.05.001---
Eye irritation06.04.05.003---
Hyperaesthesia17.02.06.004; 23.03.03.080---
Ocular hyperaemia06.04.05.004---
Oedema08.01.07.006; 14.05.06.010---
Pain08.01.08.004--
Paraesthesia17.02.06.005; 23.03.03.094--
Photophobia06.01.01.004; 17.17.02.006--
Pruritus23.03.12.001--
Rash pustular11.01.12.002; 23.03.10.003--
Scab23.03.03.004---
Skin discolouration23.03.03.005---
Skin disorder23.03.03.007---
Skin erosion23.07.03.002---
Skin exfoliation23.03.07.003---
Skin hyperpigmentation23.05.01.003--
Skin hypopigmentation23.05.02.003--
Skin irritation23.03.04.009---
Swelling08.01.03.015---
Tenderness08.01.08.005---
Ulcer08.03.06.001---
Urticaria10.01.06.001; 23.04.02.001--
Vision blurred06.02.06.007; 17.17.01.010--
Wound secretion08.01.03.035; 12.01.08.007---
The 1th Page    1 2    Next   Last    Total 2 Pages